Professor Dr Dr Harald Mischak received his PhD from the Technical University of Vienna, Austria, in 1986. Here he founded mosaiques diagnostics and mosaiques therapeutics in 2002. Currently, he is general manager of the mosaiques diagnostics GmbH, and a worldwide leading authority in the field of clinical proteome analysis, with more than 200 papers published in peer reviewed journals and more than 100 patents filed.
Dr William Mullen is based in the Institute of Cardiovascular and Medical Sciences, which includes the BHF Glasgow Cardiovascular Research Centre. The purpose of this is to integrate the expertise of clinician and basic scientists to develop personalised cardiovascular medicine. Their laboratories are fully equipped with the latest separation equipment and mass spectrometers required for biomarker research and development. Dr Mullen joined the University of Glasgow in 1998 after 18 year running his own company designing and manufacturing instrumentation used in the Pharmaceutical industry for drug metabolism studies, where he previously worked. His work in Glasgow focused on the bioactive compounds in plant products and their effect on human nutrition. He has worked on grants funded by every major food and drink vendor including the Mars Corporation and Coca Cola and is a world renowned researcher in this field. Through these studies of the bioavailability and metabolism of plant secondary metabolites and their effect on health he realised the existing biomarker in use lacked the specificity and sensitivity to detect the changes brought by nutritional interventions. This is why in 2010 he started collaboration with Prof Harald Mischak with an aim to use clinical biomarkers developed to investigate health and nutrition. Dr Mullen has over 90 peer reviewed journals since joining the University in 1998, has an H index of 32 and is a Thompson Reuters highly cited researcher.